Hengrui Pharma reports 88.9% rise in 2026 third-quarter profit on licensing deals Jiangsu Hengrui Pharmaceuticals , China's biggest drugmaker by market value, reported on Tuesday a rise of 88.9% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results